The latest price target for Colgate-Palmolive (NYSE:CL) was reported by Barclays on May 5, 2026. The analyst firm set a price target for $80.00 expecting CL to fall to within 12 months (a possible -7.67% downside). 53 analyst firms have reported ratings in the last year.

The latest analyst rating for Colgate-Palmolive (NYSE:CL) was provided by Barclays, and Colgate-Palmolive maintained their equal-weight rating.

The last upgrade for Colgate-Palmolive Co happened on April 21, 2026 when Rothschild & Co raised their price target to $100. Rothschild & Co previously had a neutral for Colgate-Palmolive Co.

The last downgrade for Colgate-Palmolive Co happened on December 11, 2025 when Argus Research changed their price target from N/A to N/A for Colgate-Palmolive Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Colgate-Palmolive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Colgate-Palmolive was filed on May 5, 2026 so you should expect the next rating to be made available sometime around May 5, 2027.

While ratings are subjective and will change, the latest Colgate-Palmolive (CL) rating was a maintained with a price target of $79.00 to $80.00. The current price Colgate-Palmolive (CL) is trading at is $86.65, which is out of the analyst’s predicted range.